Ezra Holdings Limited (NASDAQ:EZRA) Shares Shorted: Short Interest Up 405.0% in October

Ezra Holdings Limited (NASDAQ:EZRA) was the target of a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 43,558 shares, an increase of 405.0% from the September 30th total of 8,626 shares. Based on an average daily volume of 711,287 shares, the short-interest ratio is presently 0.1 days.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Wall Street Zen cut shares of Ezra from a “hold” rating to a “sell” rating in a report on Saturday, September 5th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Ezra in a report on Friday, October 2nd. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, the company presently has a consensus rating of “Sell”.

Ezra Stock Performance

Shares of NASDAQ:EZRA traded down $0.02 on Wednesday, reaching $2.18. 8,239 shares of the company were exchanged, compared to its average volume of 761,474. Ezra has a 1-year low of $1.75 and a 1-year high of $43.60. The company has a 50-day moving average of $2.53 and a 200-day moving average of $4.00.

Ezra (NASDAQ:EZRA) last released its quarterly earnings data on Thursday, July 30th. The company reported ($3.26) EPS for the quarter. The company had revenue of $2.11 million for the quarter.

Insider Activity

In other news, Director Alex Blumenfrucht sold 8,830 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $3.97, for a total transaction of $35,055.10. Following the completion of the sale, the director owned 13 shares in the company, valued at $51.61. This represents a 99.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Ben Fruchtzweig sold 7,448 shares of the stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $4.08, for a total value of $30,387.84. Following the sale, the director directly owned 5 shares of the company’s stock, valued at approximately $20.40. This represents a 99.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 34,727 shares of company stock valued at $124,161.

Ezra Company Profile

Ezra Ltd. is a medical technology company focused on improving cancer screening through magnetic resonance imaging (MRI) and artificial intelligence. Its platform is designed to help clinicians identify potential cancers earlier by analyzing MRI scans of the body and highlighting areas that may require further evaluation.

The company offers full-body and organ-specific MRI screening services through its technology platform, with the goal of making preventive cancer screening more accessible and efficient.